mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.6 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.6 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |